Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
5-hydroxytryptamine receptor 2C | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 3 | 0 | 4 | 0 | 4 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
TDP1 protein | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
AR protein | 6 | 0 | 0 | 6 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
67.9K protein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
Glutamate receptor 2 | 1 | 0 | 0 | 1 |
Caspase-2 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Luciferase | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 4 | 0 | 5 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Mu-type opioid receptor | 0 | 4 | 2 | 9 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 5 | 3 | 9 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 5 | 1 | 7 |
Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
Kappa-type opioid receptor | 0 | 5 | 1 | 7 |
Mu-type opioid receptor | 0 | 4 | 1 | 7 |
Mu-type opioid receptor | 0 | 5 | 0 | 5 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
geminin | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 6 | 0 | 6 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
GLS protein | 1 | 0 | 0 | 1 |
IDH1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
PPM1D protein | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 0 | 1 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |